A new class of drugs is emerging that aims to combat drowsiness and enhance wakefulness, similar to how Prozac transformed treatment for depression. These drugs could significantly benefit those with sleep disorders, improving their quality of life and productivity, and potentially impacting sectors like transportation and healthcare. However, concerns arise regarding the manipulation of natural sleep patterns, which could lead to unforeseen health consequences, as well as the risk of abuse and addiction in a productivity-driven society. The drugs are still in early development stages, highlighting the need for thorough research and regulations before they become widely available. Caution is advised, and individuals should consult healthcare professionals before considering these medications.